Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryo Cell International (CCEL) Income from Continuing Operations (2016 - 2026)

Cryo Cell International's Income from Continuing Operations history spans 17 years, with the latest figure at 47108.0 for Q1 2026.

  • Quarterly results put Income from Continuing Operations at 47108.0 for Q1 2026, down 83.35% from a year ago — trailing twelve months through Feb 2026 was 2665132.0 (down 2170.66% YoY), and the annual figure for FY2025 was 2429385.0, down 704.18%.
  • Income from Continuing Operations for Q1 2026 was 47108.0 at Cryo Cell International, up from 3817433.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1051679.0 in Q3 2024 to a low of 11190018.0 in Q4 2023.
  • The 5-year median for Income from Continuing Operations is 556241.0 (2024), against an average of 513555.47.
  • The sharpest move saw Income from Continuing Operations crashed 1435.61% in 2023, then soared 196.77% in 2024.
  • Year by year, Income from Continuing Operations stood at 837822.0 in 2022, then crashed by 1435.61% to 11190018.0 in 2023, then surged by 83.36% to 1861615.0 in 2024, then crashed by 105.06% to 3817433.0 in 2025, then soared by 101.23% to 47108.0 in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 47108.0, 3817433.0, and 749408.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.